The Human Antibody Response to Dengue Virus Infection

by Aravinda M. de Silva, Wahala M. P. B. Wahala
Published 2011-11-01

Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus

by William B. Messer, Duane J. Gubler, Eva Harris, Kamalanayani Sivananthan, Aravinda M. de Silva
Published 2003-07-01

Dissecting the human serum antibody response to secondary dengue virus infections.

by Bhumi Patel, Patti Longo, Michael J Miley, Magelda Montoya, Eva Harris, Aravinda M de Silva
Published 2017-05-01

Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope

by Stefan W. Metz, Ashlie Thomas, Laura White, Mark Stoops, Markus Corten, Holger Hannemann, Aravinda M. de Silva
Published 2018-04-01

Estimates of dengue force of infection in children in Colombo, Sri Lanka.

by Clarence C Tam, Hasitha Tissera, Aravinda M de Silva, Aruna Dharshan De Silva, Harold S Margolis, Ananda Amarasinge
Published 2013-01-01

In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers

by Stefan W. Metz, Emily N. Gallichotte, Alex Brackbill, Lakshmanane Premkumar, Michael J. Miley, Ralph Baric, Aravinda M. de Silva
Published 2017-07-01

Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.

by William B Messer, Boyd Yount, Kari E Hacker, Eric F Donaldson, Jeremy P Huynh, Aravinda M de Silva, Ralph S Baric
Published 2012-01-01

Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003).

by Laura J White, Ellen F Young, Mark J Stoops, Sandra R Henein, Elizabeth C Adams, Ralph S Baric, Aravinda M de Silva
Published 2021-03-01

Natural strain variation and antibody neutralization of dengue serotype 3 viruses.

by Wahala M P B Wahala, Eric F Donaldson, Ruklanthi de Alwis, Mary Ann Accavitti-Loper, Ralph S Baric, Aravinda M de Silva
Published 2010-03-01

Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes

by Daniela V. Andrade, Leah C. Katzelnick, Doug G. Widman, Angel Balmaseda, Aravinda M. de Silva, Ralph S. Baric, Eva Harris, Diane E. Griffin
Published 2017-09-01

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection

by Matthew H. Collins, Eileen McGowan, Ramesh Jadi, Ellen Young, Cesar A. Lopez, Ralph S. Baric, Helen M. Lazear, Aravinda M. de Silva
Published 2017-05-01

Unsuspected Dengue as a Cause of Acute Febrile Illness in Children and Adults in Western Nicaragua.

by Megan E Reller, Aravinda M de Silva, Jeremy J Miles, Ramesh S Jadi, Anne Broadwater, Katie Walker, Christopher Woods, Orlando Mayorga, Armando Matute
Published 2016-10-01

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.

by Emily N Gallichotte, Thomas J Baric, Boyd L Yount, Douglas G Widman, Anna Durbin, Steve Whitehead, Ralph S Baric, Aravinda M de Silva
Published 2018-02-01

Severe Dengue Epidemics in Sri Lanka, 2003–2006

by Nalaka Kanakaratne, Wahala M.P.B. Wahala, William B. Messer, Hasitha A. Tissera, Aruna Shahani, Nihal Abeysinghe, Aravinda M. de Silva, Maya Gunasekera
Published 2009-02-01

Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies

by Emily N. Gallichotte, Ellen F. Young, Thomas J. Baric, Boyd L. Yount, Stefan W. Metz, Matthew C. Begley, Aravinda M. de Silva, Ralph S. Baric
Published 2019-09-01

Oligomeric state of the ZIKV E protein defines protective immune responses

by Stefan W. Metz, Ashlie Thomas, Alex Brackbill, John Forsberg, Michael J. Miley, Cesar A. Lopez, Helen M. Lazear, Shaomin Tian, Aravinda M. de Silva
Published 2019-10-01

Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees

by David R. Martinez, Boyd Yount, Usha Nivarthi, Jennifer E. Munt, Matthew J. Delacruz, Stephen S. Whitehead, Anna P. Durbin, Aravinda M. de Silva, Ralph S. Baric
Published 2020-10-01

Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone

by Emily N. Gallichotte, Vineet D. Menachery, Boyd L. Yount, Douglas G. Widman, Kenneth H. Dinnon, Steven Hartman, Aravinda M. de Silva, Ralph S. Baric, Rebecca Ellis Dutch
Published 2017-02-01

Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses.

by Stefan W Metz, Shaomin Tian, Gabriel Hoekstra, Xianwen Yi, Michelle Stone, Katie Horvath, Michael J Miley, Joseph DeSimone, Chris J Luft, Aravinda M de Silva
Published 2016-10-01

Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype.

by Stefan W Metz, Ashlie Thomas, Alex Brackbill, Yi Xianwen, Michele Stone, Katie Horvath, Michael J Miley, Chris Luft, Joseph M DeSimone, Shaomin Tian, Aravinda M de Silva
Published 2018-09-01